Recall Register

Drug recall: Enalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with Non CRC cap and 2…

Class III FDA enforcement event 80356. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed Impurities/Degradation Specifications

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Wockhardt Limited started this drug recall on 19 Jun 2018. The firm address in the FDA record is in Karodi. FDA put the recall in Class III. FDA event 80356 has 2 product records. The first FDA enforcement report date is 18 Jul 2018. The record gives the status Terminated, with the termination date 13 Apr 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide.

Recalling firm

Wockhardt Limited, Karodi, India.

Recalling firm: The firm that the FDA record names for a recall.

Products

2 product records in the event.

FDA event 80356: product records
Recall numberProductQuantityClassStatusReport date
D-0912-2018Enalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.31,710 tabletsClass IIITerminated18 Jul 2018
D-0913-2018Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.17,628 tabletsClass IIITerminated18 Jul 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2018
367
Share of these events in Class III
29%
Product records in this event
2
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 80356. https://recallregister.com/fda/iii/80356/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide.
What quantity of product is in FDA event 80356?
The event has 2 product records. The first record gives this quantity: 31,710 tablets
How many drug recalls of 2018 have the same class?
29% of the 367 drug events that started in 2018 are in Class III.